These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37421500)

  • 41. Structural Analysis and Characterization of 4-F-α-PVP Analog 4-F-3-Methyl-α- PVP Hydrochloride.
    Wang HY; Wu J; Zhang Q; Min XF; Liu XY; Guo YL
    Fa Yi Xue Za Zhi; 2023 Apr; 39(2):144-150. PubMed ID: 37277377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT; George S
    J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gas chromatographic-electron-impact mass fragmentometric determination of lysergic acid diethylamide in urine.
    Paul BD; Mitchell JM; Burbage R; Moy M; Sroka R
    J Chromatogr; 1990 Jul; 529(1):103-12. PubMed ID: 2211923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a new psychoactive substance in seized material: the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl).
    Breindahl T; Kimergård A; Andreasen MF; Pedersen DS
    Drug Test Anal; 2017 Mar; 9(3):415-422. PubMed ID: 27476446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M; Johansen SS; Thomsen R; Linnet K
    Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.
    Cai J; Henion J
    J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A selective and sensitive method for quantitation of lysergic acid diethylamide (LSD) in whole blood by gas chromatography-ion trap tandem mass spectrometry.
    Libong D; Bouchonnet S; Ricordel I
    J Anal Toxicol; 2003; 27(1):24-9. PubMed ID: 12587679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The determination of lysergide (LSD) in urine by high-performance liquid chromatography-isotope dilution mass spectrometry (IDMS).
    White SA; Kidd AS; Webb KS
    J Forensic Sci; 1999 Mar; 44(2):375-9. PubMed ID: 10097366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Identification of Synthetic Cannabinoid New Psychoactive Substances 4F-MDMB-BUTINACA and MDMB-4en-PINACA].
    Wang KD; Yuan XL; Zhang YR; Hu JJ; Cao FQ; Chen YS
    Fa Yi Xue Za Zhi; 2021 Aug; 37(4):505-510. PubMed ID: 34726003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.
    Jang M; Kim J; Han I; Yang W
    J Pharm Biomed Anal; 2015 Nov; 115():138-43. PubMed ID: 26188861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural analysis of an lysergic acid diethylamide (LSD) analogue N-methyl-N-isopropyllysergamide (MiPLA): Insights from Rotamers in NMR spectra.
    Shoda T; Tsuji G; Kawamura M; Kurohara T; Misawa T; Kikura-Hanajiri R; Demizu Y
    Drug Test Anal; 2024 Jun; 16(6):588-594. PubMed ID: 37830386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
    Dolder PC; Liechti ME; Rentsch KM
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EASI-IMS an expedite and secure technique to screen for 25I-NBOH in blotter papers.
    de Morais DR; Barbosa IL; Cunha KF; Tripodi GL; Angolini CFF; Franco MF; de Aquino EM; Eberlin MN; Costa JL
    J Mass Spectrom; 2017 Oct; 52(10):701-706. PubMed ID: 28746793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials.
    Strano Rossi S; Odoardi S; Gregori A; Peluso G; Ripani L; Ortar G; Serpelloni G; Romolo FS
    Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1904-16. PubMed ID: 25088134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
    Verstraete AG; Van de Velde EJ
    Acta Clin Belg; 1999; 53 Suppl 1():94-6. PubMed ID: 10216992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
    Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
    J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
    Johansen SS; Jensen JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):21-8. PubMed ID: 16154519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Death after 25C-NBOMe and 25H-NBOMe consumption.
    Morini L; Bernini M; Vezzoli S; Restori M; Moretti M; Crenna S; Papa P; Locatelli C; Osculati AMM; Vignali C; Groppi A
    Forensic Sci Int; 2017 Oct; 279():e1-e6. PubMed ID: 28893436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
    Liu C; Jia W; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.